Clinical trial

A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)

NCT01055340

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE1

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2015-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Oxyntomodulin (OXM)DRUG

Comparator: Oxyntomodulin (OXM)DRUG

Comparator: Placebo [ hemaccel-containing saline]DRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01055340 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.